MS. MEAGHAN PATRICIA HOGAN FNP
Prescription History 1497316921
Nurse Practitioner in Troy, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MS. MEAGHAN PATRICIA HOGAN FNP, an active Nurse Practitioner specialist practicing in Troy, NY. Our medical registry currently tracks 42 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,912 documented patient claims. Among these therapy options, the most frequently utilized medication is Ozempic, which accounts for 180 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| OzempicSemaglutide | 180 | $1,453.63 | ▲ More than typical |
About Ozempic: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment. In 2023, this provider wrote 180 Medicare prescriptions for Ozempic, about 3.8 times the volume of the typical New York prescriber of this medication (47). Medicare paid an average of $1,453.63 per fill, versus $1,419.80 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 269.2 30-Day Fills standardized to 30-day supplies 7,860 Days of Medication total across all patients in 2023 | |||
| JardianceEmpagliflozin | 134 | $990.24▼ below NY avg | ▲ More than typical |
About Jardiance: Empagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Empagliflozin is also used in patients with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Empagliflozin is also used to treat heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Empagliflozin works by increasing the removal of sodium by your kidneys. In 2023, this provider wrote 134 Medicare prescriptions for Jardiance, about 2.9 times the volume of the typical New York prescriber of this medication (47). Medicare paid an average of $990.24 per fill, versus $1,077.31 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 236 30-Day Fills standardized to 30-day supplies 7,071 Days of Medication total across all patients in 2023 | |||
| Tresiba Flextouch U-100Insulin Degludec | 132 | $600.37▼ below NY avg | ▲ More than typical |
About Tresiba Flextouch U-100: Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2023, this provider wrote 132 Medicare prescriptions for Tresiba Flextouch U-100, about 4.6 times the volume of the typical New York prescriber of this medication (29). Medicare paid an average of $600.37 per fill, versus $678.01 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 228.5 30-Day Fills standardized to 30-day supplies 6,471 Days of Medication total across all patients in 2023 | |||
| Levothyroxine Sodium | 126 | $12.55▼ below NY avg | ≈ Typical |
About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2023, this provider wrote 126 Medicare prescriptions for Levothyroxine Sodium, about the same volume as the typical New York prescriber of this medication (129). Medicare paid an average of $12.55 per fill, versus $18.60 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 220.4 30-Day Fills standardized to 30-day supplies 6,478 Days of Medication total across all patients in 2023 | |||
| Novolog FlexpenInsulin Aspart | 120 | $837.96▼ below NY avg | ▲ More than typical |
About Novolog Flexpen: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain. In 2023, this provider wrote 120 Medicare prescriptions for Novolog Flexpen, about 3.4 times the volume of the typical New York prescriber of this medication (35). Medicare paid an average of $837.96 per fill, versus $851.21 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 199.6 30-Day Fills standardized to 30-day supplies 5,665 Days of Medication total across all patients in 2023 | |||
| Metformin Hcl | 105 | $10.28 | ≈ Typical |
About Metformin Hcl: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) In 2023, this provider wrote 105 Medicare prescriptions for Metformin Hcl, about the same volume as the typical New York prescriber of this medication (96). Medicare paid an average of $10.28 per fill, versus $8.89 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 207.5 30-Day Fills standardized to 30-day supplies 5,899 Days of Medication total across all patients in 2023 | |||
| MounjaroTirzepatide | 103 | $1,274.28 | ▲ More than typical |
About Mounjaro: Tirzepatide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. It lowers blood sugar by causing the release of your body's natural insulin and decreasing the amount of sugar your liver makes. A glucose-dependent insulinotropic polypeptide (GIP) receptor and Glucose-like peptide-1 (GLP-1) receptor agonist to enhance glycemic control in adults with TYPE 2 DIABETES MELLITUS. In 2023, this provider wrote 103 Medicare prescriptions for Mounjaro, about 4.7 times the volume of the typical New York prescriber of this medication (22). Medicare paid an average of $1,274.28 per fill, versus $1,262.88 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 120.1 30-Day Fills standardized to 30-day supplies 3,426 Days of Medication total across all patients in 2023 | |||
| Metformin Hcl ErMetformin Hcl | 95 | $21.74 | ▲ More than typical |
About Metformin Hcl Er: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) In 2023, this provider wrote 95 Medicare prescriptions for Metformin Hcl Er, about 1.8 times the volume of the typical New York prescriber of this medication (53). Medicare paid an average of $21.74 per fill, versus $11.60 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 198.2 30-Day Fills standardized to 30-day supplies 5,926 Days of Medication total across all patients in 2023 | |||
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 83 | $66.23▼ below NY avg | ▲ More than typical |
In 2023, this provider wrote 83 Medicare prescriptions for Nano 2nd Gen Pen Needle, about 2.7 times the volume of the typical New York prescriber of this medication (31). Medicare paid an average of $66.23 per fill, versus $93.39 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 178 30-Day Fills standardized to 30-day supplies 5,309 Days of Medication total across all patients in 2023 | |||
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 74 | $475.19▼ below NY avg | ▲ More than typical |
About Lantus Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2023, this provider wrote 74 Medicare prescriptions for Lantus Solostar, about 2.1 times the volume of the typical New York prescriber of this medication (36). Medicare paid an average of $475.19 per fill, versus $582.22 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 162.7 30-Day Fills standardized to 30-day supplies 4,793 Days of Medication total across all patients in 2023 | |||
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 54 | $490.43 | ▲ More than typical |
About Basaglar Kwikpen U-100: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2023, this provider wrote 54 Medicare prescriptions for Basaglar Kwikpen U-100, about 1.5 times the volume of the typical New York prescriber of this medication (35). Medicare paid an average of $490.43 per fill, versus $373.10 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 107.4 30-Day Fills standardized to 30-day supplies 3,183 Days of Medication total across all patients in 2023 | |||
| TrulicityDulaglutide | 51 | $1,208.88▼ below NY avg | ≈ Typical |
About Trulicity: Dulaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. This medication is also used to lessen the risk of a major cardiovascular event (such as heart attack or stroke) in people who already have, or are at high risk for heart/blood vessel disease. Dulaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and by decreasing the amount of sugar your liver makes. Dulaglutide is not a substitute for insulin if you need insulin treatment. In 2023, this provider wrote 51 Medicare prescriptions for Trulicity, about the same volume as the typical New York prescriber of this medication (50). Medicare paid an average of $1,208.88 per fill, versus $1,383.47 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 63.6 30-Day Fills standardized to 30-day supplies 1,822 Days of Medication total across all patients in 2023 | |||
| FarxigaDapagliflozin Propanediol | 49 | $999.29▼ below NY avg | ≈ Typical |
About Farxiga: Dapagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication is also used in people with type 2 diabetes and heart disease to lower the risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sugar by your kidneys. Dapagliflozin is also used to treat kidney disease and heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Dapagliflozin works by increasing the removal of sodium by your kidneys. In 2023, this provider wrote 49 Medicare prescriptions for Farxiga, about 1.2 times the volume of the typical New York prescriber of this medication (41). Medicare paid an average of $999.29 per fill, versus $1,020.40 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 84.3 30-Day Fills standardized to 30-day supplies 2,530 Days of Medication total across all patients in 2023 | |||
| Atorvastatin Calcium | 49 | $22.02 | ▼ Less than typical |
About Atorvastatin Calcium: Atorvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. Show more ▾ It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details. A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors. In 2023, this provider wrote 49 Medicare prescriptions for Atorvastatin Calcium, about a quarter of the volume of the typical New York prescriber of this medication (180). Medicare paid an average of $22.02 per fill, versus $13.12 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 141 30-Day Fills standardized to 30-day supplies 4,230 Days of Medication total across all patients in 2023 | |||
| NovologInsulin Aspart | 48 | $1,297.68 | ▲ More than typical |
About Novolog: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain. In 2023, this provider wrote 48 Medicare prescriptions for Novolog, about 1.9 times the volume of the typical New York prescriber of this medication (25). Medicare paid an average of $1,297.68 per fill, versus $1,084.03 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 85.8 30-Day Fills standardized to 30-day supplies 2,559 Days of Medication total across all patients in 2023 | |||
| Omnipod 5 G6 Pods (Gen 5)Insulin Pump Cart,automated,bt | 47 | $1,452.98 | ▲ More than typical |
In 2023, this provider wrote 47 Medicare prescriptions for Omnipod 5 G6 Pods (Gen 5), about 2.9 times the volume of the typical New York prescriber of this medication (16). Medicare paid an average of $1,452.98 per fill, versus $1,438.31 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 100 30-Day Fills standardized to 30-day supplies 3,000 Days of Medication total across all patients in 2023 | |||
| RybelsusSemaglutide | 45 | $1,584.71 | ▲ More than typical |
About Rybelsus: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment. In 2023, this provider wrote 45 Medicare prescriptions for Rybelsus, about 1.5 times the volume of the typical New York prescriber of this medication (30). Medicare paid an average of $1,584.71 per fill, versus $1,390.72 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 73 30-Day Fills standardized to 30-day supplies 2,190 Days of Medication total across all patients in 2023 | |||
| Glipizide ErGlipizide | 37 | $12.25▼ below NY avg | ≈ Typical |
About Glipizide Er: Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. An oral hypoglycemic agent which is rapidly absorbed and completely metabolized. In 2023, this provider wrote 37 Medicare prescriptions for Glipizide Er, about the same volume as the typical New York prescriber of this medication (36). Medicare paid an average of $12.25 per fill, versus $17.71 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 75 30-Day Fills standardized to 30-day supplies 2,217 Days of Medication total across all patients in 2023 | |||
| Humalog Kwikpen U-100Insulin Lispro | 32 | $576.58▼ below NY avg | ≈ Typical |
About Humalog Kwikpen U-100: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2023, this provider wrote 32 Medicare prescriptions for Humalog Kwikpen U-100, about the same volume as the typical New York prescriber of this medication (28). Medicare paid an average of $576.58 per fill, versus $931.67 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 40 30-Day Fills standardized to 30-day supplies 1,134 Days of Medication total across all patients in 2023 | |||
| TradjentaLinagliptin | 26 | $795.40▼ below NY avg | ≈ Typical |
About Tradjenta: Linagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used by people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Linagliptin is a diabetes drug that works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes. A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS. In 2023, this provider wrote 26 Medicare prescriptions for Tradjenta, about 79% of the volume of the typical New York prescriber of this medication (33). Medicare paid an average of $795.40 per fill, versus $832.38 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 38 30-Day Fills standardized to 30-day supplies 1,140 Days of Medication total across all patients in 2023 | |||
| Novolog PenfillInsulin Aspart | 22 | $1,607.78 | ▲ More than typical |
About Novolog Penfill: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain. In 2023, this provider wrote 22 Medicare prescriptions for Novolog Penfill, about 1.3 times the volume of the typical New York prescriber of this medication (17). Medicare paid an average of $1,607.78 per fill, versus $831.47 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36.6 30-Day Fills standardized to 30-day supplies 1,052 Days of Medication total across all patients in 2023 | |||
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 22 | $121.68 | ≈ Typical |
In 2023, this provider wrote 22 Medicare prescriptions for Ultra-Fine Mini Pen Needle, about the same volume as the typical New York prescriber of this medication (23). Medicare paid an average of $121.68 per fill, versus $80.23 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 29.8 30-Day Fills standardized to 30-day supplies 796 Days of Medication total across all patients in 2023 | |||
| BaqsimiGlucagon | 21 | $569.35 | ≈ Typical |
About Baqsimi: This medication is the same as your body's own glucagon, a natural substance that raises blood sugar by causing the body to release sugar stored in the liver. Show more ▾ It is used to treat very low blood sugar (hypoglycemia) that may cause you to need help from others. Make sure a family member or caregiver knows where you keep this medication and how to use it before you need their help. Peptides derived from proglucagon which is also the precursor of pancreatic GLUCAGON. Despite expression of proglucagon in multiple tissues, the major production site of glucagon-like peptides (GLPs) is the INTESTINAL L CELLS. GLPs include glucagon-like peptide 1, glucagon-like peptide 2, and the various truncated forms. In 2023, this provider wrote 21 Medicare prescriptions for Baqsimi, about the same volume as the typical New York prescriber of this medication (20). Medicare paid an average of $569.35 per fill, versus $512.95 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 21 30-Day Fills standardized to 30-day supplies 258 Days of Medication total across all patients in 2023 | |||
| Insulin Lispro | 20 | $68.75▼ below NY avg | ≈ Typical |
About Insulin Lispro: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2023, this provider wrote 20 Medicare prescriptions for Insulin Lispro, about the same volume as the typical New York prescriber of this medication (20). Medicare paid an average of $68.75 per fill, versus $186.19 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 21.1 30-Day Fills standardized to 30-day supplies 632 Days of Medication total across all patients in 2023 | |||
| Ultra-Fine Nano Pen NeedlePen Needle, Diabetic | 18 | $67.49▼ below NY avg | ≈ Typical |
In 2023, this provider wrote 18 Medicare prescriptions for Ultra-Fine Nano Pen Needle, about 75% of the volume of the typical New York prescriber of this medication (24). Medicare paid an average of $67.49 per fill, versus $77.60 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 43.2 30-Day Fills standardized to 30-day supplies 1,291 Days of Medication total across all patients in 2023 | |||
| Gabapentin | 16 | $26.32 | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2023, this provider wrote 16 Medicare prescriptions for Gabapentin, about a quarter of the volume of the typical New York prescriber of this medication (78). Medicare paid an average of $26.32 per fill, versus $17.62 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22 30-Day Fills standardized to 30-day supplies 563 Days of Medication total across all patients in 2023 | |||
| Ezetimibe | 16 | $18.93▼ below NY avg | ▼ Less than typical |
About Ezetimibe: Ezetimibe is used along with a low cholesterol/low fat diet and exercise to help lower cholesterol in the blood. Show more ▾ Ezetimibe may be used alone or with other drugs (such as statins or fibrates). Ezetimibe works by reducing the amount of cholesterol your body absorbs from your diet. Reducing cholesterol may help prevent strokes and heart attacks. An azetidine derivative and ANTICHOLESTEREMIC AGENT that inhibits intestinal STEROL absorption. It is used to reduce total CHOLESTEROL; LDL CHOLESTEROL, and APOLIPOPROTEINS B in the treatment of HYPERLIPIDEMIAS. In 2023, this provider wrote 16 Medicare prescriptions for Ezetimibe, about a third of the volume of the typical New York prescriber of this medication (45). Medicare paid an average of $18.93 per fill, versus $55.45 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 48 30-Day Fills standardized to 30-day supplies 1,440 Days of Medication total across all patients in 2023 | |||
| Lisinopril | 15 | $15.15 | ▼ Less than typical |
About Lisinopril: Lisinopril is used to treat high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat heart failure and to improve survival after a heart attack. Lisinopril belongs to a class of drugs known as ACE inhibitors. It works by relaxing blood vessels so blood can flow more easily. One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure. In 2023, this provider wrote 15 Medicare prescriptions for Lisinopril, about 16% of the volume of the typical New York prescriber of this medication (91). Medicare paid an average of $15.15 per fill, versus $7.67 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 45 30-Day Fills standardized to 30-day supplies 1,350 Days of Medication total across all patients in 2023 | |||
| PentipsPen Needle, Diabetic | 14 | $13.77▼ below NY avg | ▼ Less than typical |
In 2023, this provider wrote 14 Medicare prescriptions for Pentips, about 64% of the volume of the typical New York prescriber of this medication (22). Medicare paid an average of $13.77 per fill, versus $18.97 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 25 30-Day Fills standardized to 30-day supplies 689 Days of Medication total across all patients in 2023 | |||
| JanuviaSitagliptin Phosphate | 14 | $1,309.54 | ▼ Less than typical |
About Januvia: Sitagliptin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Sitagliptin is a diabetes drug that works by increasing levels of natural substances called incretins. Incretins help to control blood sugar by increasing insulin release, especially after a meal. They also decrease the amount of sugar your liver makes. A pyrazine-derived DIPEPTIDYL-PEPTIDASE IV INHIBITOR and HYPOGLYCEMIC AGENT that increases the levels of the INCRETIN hormones GLUCAGON-LIKE PEPTIDE-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). It is used in the treatment of TYPE 2 DIABETES. In 2023, this provider wrote 14 Medicare prescriptions for Januvia, about a third of the volume of the typical New York prescriber of this medication (45). Medicare paid an average of $1,309.54 per fill, versus $952.79 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 32 30-Day Fills standardized to 30-day supplies 960 Days of Medication total across all patients in 2023 | |||
| Glipizide | 14 | $5.30▼ below NY avg | ▼ Less than typical |
About Glipizide: Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin. An oral hypoglycemic agent which is rapidly absorbed and completely metabolized. In 2023, this provider wrote 14 Medicare prescriptions for Glipizide, about a third of the volume of the typical New York prescriber of this medication (34). Medicare paid an average of $5.30 per fill, versus $8.43 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 30 30-Day Fills standardized to 30-day supplies 900 Days of Medication total across all patients in 2023 | |||
| Alcohol Prep PadsAlcohol Antiseptic Pads | 13 | $4.82▼ below NY avg | ▼ Less than typical |
In 2023, this provider wrote 13 Medicare prescriptions for Alcohol Prep Pads, about a third of the volume of the typical New York prescriber of this medication (46). Medicare paid an average of $4.82 per fill, versus $16.12 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 15 30-Day Fills standardized to 30-day supplies 436 Days of Medication total across all patients in 2023 | |||
| Levemir FlexpenInsulin Detemir | 13 | $648.22 | – No State Data |
About Levemir Flexpen: Insulin detemir is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin detemir is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin detemir may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs (such as metformin, exenatide). A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS. In 2023, this provider wrote 13 Medicare prescriptions for Levemir Flexpen. Medicare paid an average of $648.22 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $648.22 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 33.2 30-Day Fills standardized to 30-day supplies 943 Days of Medication total across all patients in 2023 | |||
| Pioglitazone Hcl | 13 | $23.63 | ▼ Less than typical |
About Pioglitazone Hcl: Pioglitazone is a diabetes drug (thiazolidinedione-type, also called glitazones) used along with a proper diet and exercise program to control high blood sugar in patients with type 2 diabetes. Show more ▾ It works by helping to restore your body's proper response to insulin, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Pioglitazone is used either alone or in combination with other diabetes medications (such as metformin or a sulfonylurea such as glyburide). Talk to your doctor about the risks and benefits of pioglitazone. In 2023, this provider wrote 13 Medicare prescriptions for Pioglitazone Hcl, about a third of the volume of the typical New York prescriber of this medication (40). Medicare paid an average of $23.63 per fill, versus $15.04 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 31 30-Day Fills standardized to 30-day supplies 930 Days of Medication total across all patients in 2023 | |||
| SynthroidLevothyroxine Sodium | 13 | $84.94 | ▼ Less than typical |
About Synthroid: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2023, this provider wrote 13 Medicare prescriptions for Synthroid, about a quarter of the volume of the typical New York prescriber of this medication (50). Medicare paid an average of $84.94 per fill, versus $73.38 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25 30-Day Fills standardized to 30-day supplies 750 Days of Medication total across all patients in 2023 | |||
| FiaspInsulin Aspart (Niacinamide) | 12 | $1,711.68 | ▼ Less than typical |
About Fiasp: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. In 2023, this provider wrote 12 Medicare prescriptions for Fiasp, about half the volume of the typical New York prescriber of this medication (25). Medicare paid an average of $1,711.68 per fill, versus $1,383.06 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22 30-Day Fills standardized to 30-day supplies 660 Days of Medication total across all patients in 2023 | |||
| Losartan Potassium | 11 | $14.01 | ▼ Less than typical |
About Losartan Potassium: Losartan is used to treat high blood pressure (hypertension) and to help protect the kidneys from damage due to diabetes. Show more ▾ It is also used to lower the risk of strokes in patients with high blood pressure and an enlarged heart. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Losartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily. An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II. In 2023, this provider wrote 11 Medicare prescriptions for Losartan Potassium, about 10% of the volume of the typical New York prescriber of this medication (106). Medicare paid an average of $14.01 per fill, versus $11.17 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 27 30-Day Fills standardized to 30-day supplies 810 Days of Medication total across all patients in 2023 | |||
| Omnipod 5 G6 Intro Kit (Gen 5)Insulin Pump Cart,auto,bt/Cntr | 11 | $595.72 | ≈ Typical |
In 2023, this provider wrote 11 Medicare prescriptions for Omnipod 5 G6 Intro Kit (Gen 5), about 79% of the volume of the typical New York prescriber of this medication (14). Medicare paid an average of $595.72 per fill, versus $573.32 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 11 30-Day Fills standardized to 30-day supplies 320 Days of Medication total across all patients in 2023 | |||
| Alendronate Sodium | 11 | $3.53▼ below NY avg | ▼ Less than typical |
About Alendronate Sodium: Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates. A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis. In 2023, this provider wrote 11 Medicare prescriptions for Alendronate Sodium, about a quarter of the volume of the typical New York prescriber of this medication (49). Medicare paid an average of $3.53 per fill, versus $10.51 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 11 30-Day Fills standardized to 30-day supplies 308 Days of Medication total across all patients in 2023 | |||
| Droplet Pen NeedlePen Needle, Diabetic | 11 | $77.30 | ▼ Less than typical |
In 2023, this provider wrote 11 Medicare prescriptions for Droplet Pen Needle, about half the volume of the typical New York prescriber of this medication (19). Medicare paid an average of $77.30 per fill, versus $66.65 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 28.7 30-Day Fills standardized to 30-day supplies 861 Days of Medication total across all patients in 2023 | |||
| Amlodipine Besylate | 11 | $6.94▼ below NY avg | ▼ Less than typical |
About Amlodipine Besylate: Amlodipine is used with or without other medications to treat high blood pressure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Amlodipine belongs to a class of drugs known as calcium channel blockers. It works by relaxing blood vessels so blood can flow more easily. Amlodipine is also used to prevent certain types of chest pain (angina). It may help to increase your ability to exercise and decrease the frequency of angina attacks. It should not be used to treat attacks of chest pain when they occur. Use other medications (such as sublingual nitroglycerin) to relieve attacks of chest pain as directed by your doctor. A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION. In 2023, this provider wrote 11 Medicare prescriptions for Amlodipine Besylate, about 8% of the volume of the typical New York prescriber of this medication (145). Medicare paid an average of $6.94 per fill, versus $7.83 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 33 30-Day Fills standardized to 30-day supplies 990 Days of Medication total across all patients in 2023 | |||
| Xigduo XrDapaglifloz Propaned/Metformin | 11 | $783.95▼ below NY avg | ▼ Less than typical |
About Xigduo Xr: This medication is a combination of 2 drugs: dapagliflozin and metformin. Show more ▾ It is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication is also used to treat kidney disease or heart failure in people with type 2 diabetes. It may help you live longer and lower your risk of going to the hospital for heart failure. This medication works by helping to restore your body's proper response to the insulin you naturally produce. It also increases the removal of sugar by your kidneys, decreases how much sugar is made in your liver, and decreases how much sugar your body takes in through your stomach and intestines. In 2023, this provider wrote 11 Medicare prescriptions for Xigduo Xr, about a third of the volume of the typical New York prescriber of this medication (35). Medicare paid an average of $783.95 per fill, versus $996.03 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 15 30-Day Fills standardized to 30-day supplies 450 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for MS. MEAGHAN PATRICIA HOGAN FNP is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Nurse Practitioner prescribing approach at this Troy, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NY prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
